The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases

被引：7
作者：
Sharif, Arazu [1 ,5 ]
Mamo, John [1 ,2 ]
Lam, Virginie [1 ,3 ]
Al-Salami, Hani [1 ,5 ]
Mooranian, Armin [1 ,5 ]
Watts, Gerald F. [4 ]
Clarnette, Roger [4 ]
Luna, Giuseppe [5 ]
Takechi, Ryu [1 ,3 ]
机构：
[1] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Perth, WA, Australia
[2] Perron Inst Neurol & Translat Res, Perth, WA, Australia
[3] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia
[4] Univ Western Australia, Sch Med, Fac Hlth & Med Sci, Perth, WA, Australia
[5] Curtin Univ, Fac Hlth Sci, Curtin Med Sch, Perth, WA, Australia
来源：
TRANSLATIONAL NEURODEGENERATION | 2024年 / 13卷 / 01期
基金：
英国医学研究理事会;
关键词：
Neurodegenerative disease; Probucol; Probucol analogues; Inflammation; Blood-brain barrier; Oxidative stress; Amyloid-beta; BLOOD-BRAIN-BARRIER; AMYLOID-BETA PEPTIDE; CHOLESTEROL-LOWERING DRUG; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; SIGNALING PATHWAY; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT BO-653;
D O I：
10.1186/s40035-024-00398-w
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Neurodegenerative disorders present complex pathologies characterized by various interconnected factors, including the aggregation of misfolded proteins, oxidative stress, neuroinflammation and compromised blood-brain barrier (BBB) integrity. Addressing such multifaceted pathways necessitates the development of multi-target therapeutic strategies. Emerging research indicates that probucol, a historic lipid-lowering medication, offers substantial potential in the realm of neurodegenerative disease prevention and treatment. Preclinical investigations have unveiled multifaceted cellular effects of probucol, showcasing its remarkable antioxidative and anti-inflammatory properties, its ability to fortify the BBB and its direct influence on neural preservation and adaptability. These diverse effects collectively translate into enhancements in both motor and cognitive functions. This review provides a comprehensive overview of recent findings highlighting the efficacy of probucol and probucol-related compounds in the context of various neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and cognitive impairment associated with diabetes.
引用
收藏
页数：12
相关论文
共 126 条
[91]   Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration [J].
Sankowski, Roman ;
Mader, Simone ;
Valdes-Ferrer, Sergio Ivan .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
[92]   PROBUCOL MITIGATES STREPTOZOTOCIN-INDUCED COGNITIVE AND BIOCHEMICAL CHANGES IN MICE [J].
Santos, D. B. ;
Colle, D. ;
Moreira, E. L. G. ;
Peres, K. C. ;
Ribeiro, R. P. ;
dos Santos, A. A. ;
de Oliveira, J. ;
Hort, M. A. ;
de Bem, A. F. ;
Farina, M. .
NEUROSCIENCE, 2015, 284 :590-600
[93]   Probucol Protects Neuronal Cells Against Peroxide-Induced Damage and Directly Activates Glutathione Peroxidase-1 [J].
Santos, Danubia B. ;
Colle, Dirleise ;
Moreira, Eduardo L. G. ;
Santos, Alessandra A. ;
Hort, Mariana A. ;
Santos, Karin ;
Oses, Jean P. ;
Razzera, Guilherme ;
Farina, Marcelo .
MOLECULAR NEUROBIOLOGY, 2020, 57 (08) :3245-3257
[94]   Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice [J].
Santos, Danubia B. ;
Peres, Kaite C. ;
Ribeiro, Renata P. ;
Colle, Dirleise ;
dos Santos, Alessandra A. ;
Moreira, Eduardo L. G. ;
Souza, Diogo O. G. ;
Figueiredo, Claudia P. ;
Farina, Marcelo .
EXPERIMENTAL NEUROLOGY, 2012, 233 (02) :767-775
[95]   Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease [J].
Santos, Danubia Bonfanti ;
Colle, Dirleise ;
Gasnhar Moreira, Eduardo Luiz ;
Hort, Mariana Appel ;
Godoi, Marcelo ;
Le Douaron, Gael ;
Braga, Antonio Luiz ;
Assreuy, Jamil ;
Michel, Patrick Pierre ;
Prediger, Rui Daniel ;
Raisman-Vozari, Rita ;
Farina, Marcelo .
MOLECULAR NEUROBIOLOGY, 2017, 54 (02) :1513-1530
[96]   MDL-29311, AN ANALOG OF PROBUCOL, DECREASES TRIGLYCERIDES IN RATS BY INCREASING HEPATIC-CLEARANCE OF VERY-LOW-DENSITY LIPOPROTEIN [J].
SHEETZ, MJ ;
BARNHART, RL ;
JACKSON, RL ;
ROBINSON, KM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (02) :233-240
[97]   Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases [J].
Song, Ke ;
Li, Yuanyuan ;
Zhang, Hanlai ;
An, Na ;
Wei, Yufei ;
Wang, Liqin ;
Tian, Chao ;
Yuan, Mengchen ;
Sun, Yikun ;
Xing, Yanwei ;
Gao, Yonghong .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
[98]   INDUCTION OF ALZHEIMER-LIKE BETA-AMYLOID IMMUNOREACTIVITY IN THE BRAINS OF RABBITS WITH DIETARY-CHOLESTEROL [J].
SPARKS, DL ;
SCHEFF, SW ;
HUNSAKER, JC ;
LIU, HC ;
LANDERS, T ;
GROSS, DR .
EXPERIMENTAL NEUROLOGY, 1994, 126 (01) :88-94
[99]   IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 [J].
Sun, Hong ;
Saeedi, Pouya ;
Karuranga, Suvi ;
Pinkepank, Moritz ;
Ogurtsova, Katherine ;
Duncan, Bruce B. ;
Stein, Caroline ;
Basit, Abdul ;
Chan, Juliana C. N. ;
Mbanya, Jean Claude ;
Pavkov, Meda E. ;
Ramachandaran, Ambady ;
Wild, Sarah H. ;
James, Steven ;
Herman, William H. H. ;
Zhang, Ping ;
Bommer, Christian ;
Kuo, Shihchen ;
Boyko, Edward J. J. ;
Magliano, Dianna J. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 183
[100]   Anti-atherogenic antioxidants regulate the expression and function of proteasome α-type subunits in human endothelial cells [J].
Takabe, W ;
Kodama, T ;
Hamakubo, T ;
Tanaka, K ;
Suzuki, T ;
Aburatani, H ;
Matsukawa, N ;
Noguchi, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :40497-40501
45678910111213